BCL2L1 Antikörper (Thr47)
Kurzübersicht für BCL2L1 Antikörper (Thr47) (ABIN2134610)
Target
Alle BCL2L1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- Thr47
-
Immunogen
- BCLXL antibody was raised in Rabbit using a synthetic non-phosphopeptide derived from human BCL-XL around the phosphorylation site of Thr47 (M-E-TP-P-S) as the immunogen
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- WB: 1:500-1:1000, IHC: 1:50-1:100, IF: 1:100-1:500, ELISA: 1:5000
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Konzentration
- Lot specific
-
Buffer
- PBS buffer (without Mg2+and Ca2+), pH 7.4, 150 mM NaCl with 0.02 % sodium azide and 50 % glycerol
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Store at -20 °C for 1 year, store at 2-8 °C for up to 1 month
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store at -20 °C for 1 year, store at 2-8 °C for up to 1 month
-
-
- BCL2L1 (BCL2-Like 1 (BCL2L1))
-
Andere Bezeichnung
- BCLXL
-
Pathways
- Apoptose, Negative Regulation of intrinsic apoptotic Signaling
Target
-